American Century Investment Management, Inc., American Century ETF Trust, American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing aggregate holdings in Cabot Corporation common stock as of September 30, 2026.

Key Highlights

  • Event date: The ownership positions reported are as of September 30, 2026.
  • American Century Investment Management stake: 3,327,668 shares beneficially owned, representing 6.4% of Cabot Corporation common stock, with sole voting and sole dispositive power over all shares.
  • American Century ETF Trust stake: 3,178,152 shares beneficially owned, representing 6.2% of Cabot Corporation common stock, with sole voting and sole dispositive power over all shares.
  • No shared power: All four reporting persons reported zero shared voting power and zero shared dispositive power.
  • Corporate structure: American Century Investment Management, Inc. is disclosed as a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.
  • Ordinary course certification: The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

American Century Discloses Position in Cabot Corporation

Cabot Corporation, listed on the NYSE under the ticker NYSE:CBT and headquartered at Two Seaport Lane, Suite 1400, Boston, Massachusetts 02210, is the issuer of the common stock covered by this amended filing. Cabot Corporation is a specialty chemicals and performance materials company whose common stock is the subject of the ownership disclosures made by the four reporting persons, all organized under Delaware law and operating from 4500 Main Street, 9th Floor, Kansas City, Missouri 64111.

According to the filing, American Century Investment Management, Inc. (ACIM) reported sole voting power and sole dispositive power over 3,327,668 shares, equal to 6.4% of Cabot Corporation's outstanding common stock. American Century Companies, Inc. (ACC) and Stowers Institute for Medical Research each reported identical aggregate beneficial ownership of 3,327,668 shares, also at 6.4%, consistent with their roles as parent holding company and controlling entity, respectively. American Century ETF Trust reported a separate position of 3,178,152 shares, representing 6.2% of the class.

The filing further discloses that "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." The filing notes that no single client advised by ACIM holds more than 5% of Cabot Corporation's common stock. ACIM is identified as an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, and a wholly-owned subsidiary of ACC.

What Was Disclosed

Four affiliated entities, led by American Century Investment Management, Inc., reported beneficial ownership positions in Cabot Corporation common stock as of September 30, 2026, with the largest stake at 3,327,668 shares, or 6.4% of the class, held with sole voting and dispositive power and no shared control.